California State Teachers Retirement System Prometheus Biosciences, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$103.46 - $126.29 $77,595 - $94,717	-750 Reduced 2.2%	33,364 $3.58 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $490,091 - $1.59 Million	13,591 Added 66.22%	34,114 $3.75 Million
Q3 2022 Nov 18, 2022	SELL	$28.17 - $59.01 $11,183 - $23,426	-397 Reduced 1.9%	20,523 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$22.39 - $38.94 $44,242 - $76,945	-1,976 Reduced 8.63%	20,920 $591,000
Q1 2022 May 16, 2022	SELL	$30.13 - $50.0 $98,766 - $163,900	-3,278 Reduced 12.52%	22,896 $865,000
Q4 2021 Feb 15, 2022	BUY	$22.28 - $39.54 $447,850 - $794,793	20,101 Added 330.99%	26,174 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$20.89 - $26.96 $199,311 - $257,225	-9,541 Reduced 61.11%	6,073 $144,000
Q2 2021 Aug 16, 2021	BUY	$16.8 - $29.65 $262,315 - $462,955	15,614 New	15,614 $383,000

Others Institutions Holding RXDX

# of Institutions

Shares Held

29.6K

Call Options Held

Put Options Held

View Full List

About Prometheus Biosciences, Inc.

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

More about RXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account